Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > Amarantus BioScience Holdings, Inc. (AMBS)

Amarantus BioScience (AMBS) <u>Price Target $2.25 By Fall</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BCNstocks Member Profile
 
Followed By 279
Posts 31,170
Boards Moderated 1
Alias Born 08/28/10
160x600 placeholder
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/19/2014 4:15:04 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/15/2014 5:00:14 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/4/2014 6:56:01 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/4/2014 4:07:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/2/2014 5:26:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/29/2014 8:36:44 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/27/2014 4:00:45 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 8/19/2014 4:55:16 PM
EDISON EQUITY RESEARCH - AMARANTUS BIOSCIENCE "InvestorsHub NewsWire" - 8/19/2014 1:28:24 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/15/2014 4:14:47 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/14/2014 5:20:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 5:15:32 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 8/8/2014 4:26:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 4:05:37 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/1/2014 7:24:11 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/1/2014 4:15:58 PM
Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R) "GlobeNewswire Inc." - 8/1/2014 9:25:23 AM
Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig "GlobeNewswire Inc." - 8/1/2014 8:00:00 AM
The 3rd Alzheimer's-Focused #C4CT Concussion Summit Convenes Today at the United Nations "GlobeNewswire Inc." - 7/31/2014 10:48:22 AM
Registration for the 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interest "GlobeNewswire Inc." - 7/30/2014 8:00:00 AM
Amarantus Amends LymPro LP-002 Clinical Protocol to Report Interim Data at #C4CT Presentation "GlobeNewswire Inc." - 7/30/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/28/2014 4:17:03 PM
Sidney Rice and Ben Utecht Talk to NFL Network's Andrea Kremer and ESPN's Andrew Brandt at Upcoming #C4CT Concussion Awarenes... "GlobeNewswire Inc." - 7/28/2014 3:16:13 PM
Amarantus Appoints Donald D. Huffman to Board of Directors "GlobeNewswire Inc." - 7/28/2014 8:09:53 AM
Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at Uni... "GlobeNewswire Inc." - 7/23/2014 11:34:02 AM
BCNstocks   Tuesday, 02/26/13 12:36:25 PM
Re: None
Post # of 108646 
Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review:

Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review. AMBS has a huge upside, look for this small biotech to take off soon on some very good news that we are hearing. By Fall today's share price will only be a distant memory!


http://biotechnewsstockreview.blogspot.com/2013/01/amarantus-bioscience-ambs-price-target.html



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist